Confidant Classes for Career Consultancy and Coaching Classes

Share Post

The US Food and Drug Administration has issued an emergency use authorization for Remdesivir, an investigational antiviral drug. With this authorization, physicians in the United States are now authorized to use the medication to treat patients with severe cases of COVID-19.

Remdesivir is not new, It was originally developed to treat Ebola and has also been laboratory tested against SARS and MERS, two other coronaviruses that infect humans in much the same way as the virus that causes COVID-19. It has never reached the approval stage for these uses, but in the past four months, scientists have desperately searched for options to help mitigate the coronavirus pandemic, and have turned to ancient drugs that could be reused.

Remdesivir has traveled an unprecedented path toward regulatory approval, making it one of the most promising treatments for COVID-19 to date. Remdesivir is not a vaccine and therefore cannot prevent infection; Instead, it works by attacking the virus once it has already spread within the body. Here is an overview of how the COVID-19 virus spreads in the human body and how the drug slows down this process.

  1. Virus enters a cell: Viruses cannot multiply without using the protein-producing machinery of a cell. Therefore, they must first enter a healthy cell. Coronaviruses, like the one caused by COVID-19, have a layer of sharp proteins that allow them to bind to cells.
  2. The virus releases the genetic code: the virus fuses with the cell and, once inside, releases a strand of RNA. Like a plan, RNA is a chain of genetic codes that has instructions for making exact copies of the virus.
  3. The genetic code is converted into proteins: tiny particles in the host cell, called ribosomes, are equipped to read genetic material. When the RNA from the virus crosses the ribosome, the ribosome produces viral proteins.
  4. Proteins make copies: Viral proteins are necessary to make copies of viral RNA, as well as other parts of the virus, such as the outer peaks and the membrane. As more and more protein and RNA chains are made, they proliferate, making exponentially more copies that fill the cell.
  5. The viral parts are assembled: the viral parts use mechanisms in the host cell to unite, forming a complete virus. Once fully assembled, the virus can leave the cell to find other healthy cells and begin the process again.
  6. Remdesivir blocks replication: Remdesivir mimics part of the viral RNA. During the copy process, it is inserted into the RNA strand. Once bound, the drug prevents further copies, leaving the RNA chain incomplete and unable to produce critical viral parts.
  7. The virus slows down: hindered by the drug, the entire replication process slows down. This means that fewer viruses are assembled. Defective viruses with partial RNA cannot replicate in other cells.

Mastering CUET (PG) General Paper: A Syllabus-wise Guide to Preparation

Mastering CUET (PG) General Paper: A Syllabus-wise Guide to Preparation The CUET (PG) or Common University Entrance Test for Postgraduate…
Read More

Comprehensive Guide to the CUET (PG) B.Ed Exam Syllabus

Comprehensive Guide to the CUET (PG) B.Ed Exam Syllabus The Common University Entrance Test (CUET) for postgraduate programs, including the…
Read More

CTET Result 2024 December: A Complete Guide

CTET Result 2024 December: A Complete Guide The Central Board of Secondary Education (CBSE) has officially announced the results for…
Read More

IGNOU Launches Bachelor of Arts Programme in Micro, Small, and Medium Enterprises (BAMSME)

IGNOU Launches Bachelor of Arts Programme in Micro, Small, and Medium Enterprises (BAMSME) The Indira Gandhi National Open University (IGNOU)…
Read More

MH-CET Revised Schedule 2025: Key Updates and Application Process

MH-CET Revised Schedule 2025: Key Updates and Application Process The Maharashtra State Common Entrance Test (CET) Cell has announced significant…
Read More

ICMAI CMA Foundation Results 2024 Declared: Here’s How to Check Your Score

ICMAI CMA Foundation Results 2024 Declared: Here’s How to Check Your Score The Institute of Cost Accountants of India (ICMAI)…
Read More

The Rising Representation of Female Teachers in India’s Schools: Key Insights from 2023-24 Data

The Rising Representation of Female Teachers in India’s Schools: Key Insights from 2023-24 Data The gender dynamics in India’s school…
Read More

Exploring the New E-Student Visa and Study in India Portal

Exploring the New E-Student Visa and Study in India Portal The Ministry of Home Affairs has unveiled two specialized visa…
Read More

CUET PG 2025 | Key Updates, Increased Fees, and New Changes

CUET PG 2025: Key Updates, Increased Fees, and New Changes The Common University Entrance Test for Postgraduate (CUET PG) 2025…
Read More

CUET PG 2025 | Unlock Your Path to Success

CUET PG 2025 | Unlock Your Path to Success The journey towards achieving your postgraduate dreams begins now! The National…
Read More

AatmNirbhar Bharat (4) AIBE (8) AIBE17 (4) BCI (4) CACP (3) CBSE (4) CLAT (8) CLAT 2025 (6) CORONA VACCINE (3) Coronavirus (18) COVID 19 (14) COVID19 (3) CUET (4) CUET PG (9) CUET UG (12) CUET UG 2023 (14) DU Admission (4) Facebook (5) Fiscal deficit (4) fiscal stimulus (4) FOREIGN EXCHANGE RESERVES (3) GDP (3) GI Tag (5) GI TAGS In iNDIA (3) GST (5) GST COMPENSATION (4) indian economy (20) INDO-CHINA BORDER DISPUTE (3) INDO-CHINA CONFLICT (6) JIO (5) lockdown (6) MONETARY POLICY COMMITTEE (4) MPC (5) MSP (3) NIRF (3) nobel prize 2020 (5) NTA (4) PMI (3) RAFALE FIGHTER JET (3) RBI (12) RELIANCE INDUSTRIES LIMITED (4) REPO Rate (4) RIL (8) Study Abroad (4) UNIVERSITY OF DELHI (5)

About Post Author